Andreas Roidl

1.0k total citations
27 papers, 817 citations indexed

About

Andreas Roidl is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Andreas Roidl has authored 27 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Andreas Roidl's work include MicroRNA in disease regulation (8 papers), Cancer Cells and Metastasis (7 papers) and RNA Interference and Gene Delivery (4 papers). Andreas Roidl is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer Cells and Metastasis (7 papers) and RNA Interference and Gene Delivery (4 papers). Andreas Roidl collaborates with scholars based in Germany, United States and Austria. Andreas Roidl's co-authors include Ernst Wagner, Florian Kopp, Prajakta Oak, Adam Hermawan, Wolfhard Bandlow, Pjotr Knyazev, Axel Ullrich, Johannes Bange, Sushil Kumar and Georg J. Arnold and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Andreas Roidl

27 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Roidl Germany 15 636 247 206 55 49 27 817
Fenil Shah United States 11 699 1.1× 110 0.4× 144 0.7× 60 1.1× 41 0.8× 18 816
Aghdass Rasouli‐Nia Canada 14 1.2k 1.8× 257 1.0× 357 1.7× 50 0.9× 53 1.1× 22 1.3k
Chikezie O. Madu United States 12 468 0.7× 179 0.7× 122 0.6× 51 0.9× 107 2.2× 21 751
Marina Stantic Australia 12 449 0.7× 225 0.9× 266 1.3× 43 0.8× 49 1.0× 14 699
Qingming Fang United States 19 796 1.3× 191 0.8× 168 0.8× 33 0.6× 23 0.5× 38 950
Chunfang Hu China 14 421 0.7× 158 0.6× 225 1.1× 40 0.7× 35 0.7× 36 752
Małgorzata Sztiller-Sikorska Poland 16 405 0.6× 162 0.7× 157 0.8× 54 1.0× 28 0.6× 21 537
Dandan Yuan China 17 389 0.6× 153 0.6× 243 1.2× 79 1.4× 99 2.0× 50 792
Sheetal Sharma India 12 907 1.4× 172 0.7× 198 1.0× 24 0.4× 25 0.5× 16 1.1k
Dali Zong United States 17 748 1.2× 167 0.7× 318 1.5× 41 0.7× 46 0.9× 27 873

Countries citing papers authored by Andreas Roidl

Since Specialization
Citations

This map shows the geographic impact of Andreas Roidl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Roidl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Roidl more than expected).

Fields of papers citing papers by Andreas Roidl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Roidl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Roidl. The network helps show where Andreas Roidl may publish in the future.

Co-authorship network of co-authors of Andreas Roidl

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Roidl. A scholar is included among the top collaborators of Andreas Roidl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Roidl. Andreas Roidl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roidl, Andreas, Christoph Müller, Aditi Mehta, et al.. (2024). Cellular EMT-status governs contact guidance in an electrospun TACS-mimicking in vitro model. Materials Today Bio. 30. 101401–101401. 3 indexed citations
2.
BRIEGER, E.M., Chase P. Broedersz, Stefan Zahler, et al.. (2024). Unraveling the metastasis‐preventing effect of miR‐200c in vitro and in vivo. Molecular Oncology. 19(4). 1029–1053. 1 indexed citations
3.
Mehta, Aditi, et al.. (2023). An In Vitro Approach to Model EMT in Breast Cancer. International Journal of Molecular Sciences. 24(9). 7757–7757. 9 indexed citations
4.
Giopanou, Ioanna, Adam Hermawan, Stefan Datz, et al.. (2020). Synergistic Combination of Calcium and Citrate in Mesoporous Nanoparticles Targets Pleural Tumors. Chem. 7(2). 480–494. 13 indexed citations
5.
Reichel, Marco, et al.. (2020). Synthesis, structural and toxicological investigations of quarternary phosphonium salts containing the P-bonded bioisosteric CH2F moiety. New Journal of Chemistry. 44(33). 14306–14315. 4 indexed citations
6.
Reichel, Marco, et al.. (2020). Tuning the toxixity of phosphonium based biocides using the bioisosteric CH 2 F moiety. Phosphorus, sulfur, and silicon and the related elements. 195(11). 947–948. 1 indexed citations
7.
Fröhlich, Thomas, et al.. (2019). Downregulation of GRK5 hampers the migration of breast cancer cells. Scientific Reports. 9(1). 15548–15548. 14 indexed citations
8.
Schreiber, Christoph, Florian Gegenfurtner, Stefan Zahler, et al.. (2019). Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A. PLoS ONE. 14(11). e0224314–e0224314. 19 indexed citations
9.
Wagner, Ernst, et al.. (2018). MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators. The Breast. 43. 31–38. 26 indexed citations
10.
Fröhlich, Thomas, et al.. (2018). A proteomic analysis of an in vitro knock-out of miR-200c. Scientific Reports. 8(1). 6927–6927. 6 indexed citations
11.
Schreiber, Christoph, et al.. (2016). Ring-Shaped Microlanes and Chemical Barriers as a Platform for Probing Single-Cell Migration. Scientific Reports. 6(1). 26858–26858. 15 indexed citations
12.
Kopp, Florian, Adam Hermawan, Prajakta Oak, et al.. (2014). Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells. Translational Oncology. 7(6). 702–711. 10 indexed citations
13.
Kopp, Florian, Adam Hermawan, Prajakta Oak, et al.. (2014). Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration. Molecular Cancer. 13(1). 16–16. 54 indexed citations
14.
Kubisch, Rebekka, Lilja Meissner, Stefan Krebs, et al.. (2013). A Comprehensive Gene Expression Analysis of Resistance Formation upon Metronomic Cyclophosphamide Therapy. Translational Oncology. 6(1). 1–IN3. 29 indexed citations
15.
Kopp, Florian, et al.. (2013). De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells. Gene Therapy. 20(11). 1104–1109. 13 indexed citations
16.
Kopp, Florian, Prajakta Oak, Ernst Wagner, & Andreas Roidl. (2012). miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression. PLoS ONE. 7(11). e50469–e50469. 103 indexed citations
17.
Oak, Prajakta, Florian Kopp, Chitra Thakur, et al.. (2012). Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2‐positive cancer cells and cancer stem cells. International Journal of Cancer. 131(12). 2808–2819. 64 indexed citations
18.
Roidl, Andreas, et al.. (2009). Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation. Clinical Cancer Research. 15(6). 2058–2066. 81 indexed citations
19.
Roidl, Andreas, Willy Wong, S. Streit, et al.. (2009). The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells. Oncogene. 29(10). 1543–1552. 46 indexed citations
20.
Roidl, Andreas, et al.. (2002). Yeast Rio1p is the founding member of a novel subfamily of protein serine kinases involved in the control of cell cycle progression. Molecular Microbiology. 44(2). 309–324. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fenil Shah Breakdown of academic impact, for papers by Aghdass Rasouli‐Nia Breakdown of academic impact, for papers by Chikezie O. Madu Breakdown of academic impact, for papers by Marina Stantic Breakdown of academic impact, for papers by Qingming Fang Breakdown of academic impact, for papers by Chunfang Hu Breakdown of academic impact, for papers by Małgorzata Sztiller-Sikorska Breakdown of academic impact, for papers by Dandan Yuan Breakdown of academic impact, for papers by Sheetal Sharma Breakdown of academic impact, for papers by Dali Zong
Rankless by CCL
2026